exp3174 has been researched along with curcumin in 1 studies
Studies (exp3174) | Trials (exp3174) | Recent Studies (post-2010) (exp3174) | Studies (curcumin) | Trials (curcumin) | Recent Studies (post-2010) (curcumin) |
---|---|---|---|---|---|
236 | 29 | 43 | 16,336 | 593 | 12,705 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, FY; Liu, AC; Liu, T; Lou, HX; Xing, J; Zhao, LX | 1 |
1 other study(ies) available for exp3174 and curcumin
Article | Year |
---|---|
Pre-treatment with curcumin enhances plasma concentrations of losartan and its metabolite EXP3174 in rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antioxidants; Area Under Curve; Chromatography, High Pressure Liquid; Curcumin; Female; Imidazoles; Losartan; Male; Rats; Rats, Wistar; Tandem Mass Spectrometry; Tetrazoles | 2012 |